Your blog category
Updated July 25, 2026 with the committee’s final results. If you follow the peptide space at all, you saw the headlines this week. The FDA “voted on peptides.” Some posts called it a ban. Others pushed a buy-now-before-it-is-gone panic. Both readings were wrong, and if you are researching BPC-157, TB-500, MOTS-C, Semax, Epitalon, or DSIP, […]
TB-500 is one of the most consistently studied research peptides in the tissue repair space. It shows up in cardiac research, wound healing studies, muscle injury models, tendon research, and neurological investigations — sometimes in the same published paper. That range of research applications isn’t coincidental. It reflects something specific about TB-500’s mechanism that distinguishes […]
BPC-157 is probably the most discussed research peptide in circulation right now. It shows up in academic journals, biohacking forums, sports medicine circles, and peptide research communities alike — often with dramatically different framings depending on who’s writing about it. This guide covers what BPC-157 actually is at a molecular level, what the published preclinical […]